Putative Activator of 90 kDa Heat Shock Protein ATPase Homolog 2 (AHSA2) Antibody

Este producto es parte de AHSA1 - Activator of 90 kDa Heat Shock Protein ATPase Homolog 1
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Putative Activator of 90 kDa Heat Shock Protein ATPase Homolog 2 (AHSA2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx307785
tested applications
ELISA, WB, IHC

Description

AHSA2 Antibody is a Rabbit Polyclonal against AHSA2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Putative Activator of 90 kDa Heat Shock Protein ATPase Homolog 2 (AHSA2)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1/500 - 1/5000, IHC: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q719I0
Gene ID
130872
NCBI Accession
NP_001308229.1, NM_001321300.1
Alias
AHA1, C14orf3, hAha1, p38
Background
Antibody anti-AHSA1
Status
RUO

Descripción

Activator of 90 kDa Heat Shock Protein ATPase Homolog 1 (AHSA1) is a co-chaperone protein that enhances the ATPase activity of Hsp90, a molecular chaperone essential for the proper folding, stability, and function of numerous client proteins, including kinases, receptors, and transcription factors. AHSA1 facilitates the Hsp90 chaperone cycle, ensuring efficient protein maturation and stress response. Overexpression of AHSA1 has been linked to cancer, as it enhances the stability of oncogenic client proteins required for tumor progression and survival. AHSA1 is a promising target for cancer therapies aimed at disrupting Hsp90 function. Beyond cancer, AHSA1 also plays a role in protein quality control and cellular stress responses, contributing to proteostasis under normal and pathological conditions.

Related Products

FNab00232

AHSA1 antibody

Cochaperone that stimulates HSP90 ATPase activity(By similarity). May affect a step in the endoplasmic reticulum to Golgi trafficking.

Ver Producto
P4320

Recombinant Human AHSA1

Ver Producto
P6078

Recombinant Human AHSA2P

Ver Producto